Sell
(Testnet06 — prices are in test KDA.)
Listing
Listing puts your token up at a fixed price in KDA. You sign it as the owner; the token stays in your custody (the contract blocks transfers and cross-chain moves while listed — nothing needs to be “deposited”).
When you list, the contract snapshots the platform fee rate onto your listing. Today that’s 2.5%. If the platform rate ever changes (it can move only within the immutable 0–5% band), your live listing keeps the rate it was created with — a rate change can never quietly alter a sale you already advertised.
Rules the contract enforces at listing time:
- you must be the owner, and the token must be resident on this chain;
- price must be positive and within KDA’s precision;
- a royalty-bearing token can’t be listed at a dust price whose royalty rounds to zero.
What a sale pays out
For a price P, minted royalty r bps, snapshotted fee f bps:
| Leg | Amount | Goes to |
|---|---|---|
| Creator royalty | P × r / 10000 |
the creator, always |
| Platform fee | P × f / 10000 |
the Smart Pacts funding account (on this chain) |
| Seller proceeds | the exact remainder | you |
All three legs happen inside the buyer’s single transaction, from an escrow the
contract itself controls, and the contract asserts the legs sum to exactly P. If you
are the creator selling your own work, royalty + proceeds arrive together.
Worked example — price 100, royalty 5%, fee 2.5%: creator receives 5, platform 2.5, seller 92.5.
Re-pricing and delisting
There is no “edit price”: delist, then list again at the new price (two cheap transactions). Delisting is instant and owner-only.
Two things worth knowing:
- Re-listing snapshots the current platform fee rate.
- A buyer who signed for your old price cannot be charged the new one — their purchase authorizes an exact amount, so a re-price simply makes their stale transaction fail.
While listed
- The token cannot be gifted or moved cross-chain (delist first).
- Anyone can buy it at any moment — a listing is a live, binding offer.
- Your only lever is delisting; there are no private reserves or approvals.